跳至主要内容
临床试验/NCT02090244
NCT02090244已完成4 期

Förbättrar PTH Postero-lateral fusionsläkning Vid Ryggkirurgi?

University Hospital, Linkoeping2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
The rate of bone healing after spinal stenosis surgery

研究概览

简要总结

Parathyroid (PTH) hormone has been shown to enhance fracture healing in animal studies. There are so far only three published papers concerning humans. Postero-lateral fusions have shown a healing rate of less than 50% after bone. The purpose of this study is to determine if PTH 1-34 (teriparatide) improves the healing rate and the clinical course after spinal stenosis surgery.

详细描述

100 patients undergoing surgery due to spinal stenosis and intraoperatively treated with autologous bone graft, will be randomised to either 4 weeks of daily injections with teriparatide or control.

Primary outcome: The rate of healing at 6 months on CT Scans. Secondary outcomes; Pain (VAS), function (Oswestry Disability Index), quality of life (EQ-5D) at 3 and 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • lumbar spinal stenosis operated on with decompression and bone grafting. All ages are accepted, but women must be postmenopausal.

排除标准

  • •dementia or psychiatric disorder
  • known malignancy < 5 years prior to fracture
  • calcium above reference value
  • signs of liver disease
  • creatinine over ref. value
  • inflammatory joint disease
  • alcohol or drug abuse
  • oral corticosteroid medication
  • long-term NSAID-treatment (=> 3 months prior to fracture)

研究组 & 干预措施

Teriparatide

Experimental

One injection daily for 4 weeks

干预措施: Teriparatide (Drug)

结局指标

主要结局

The rate of bone healing after spinal stenosis surgery

时间窗: 6 months + more than 2 years postoperatively.

A radiologist, blinded to the treatment, will review all CT scans and judge whether there is a bony healing between the vertebrae.

次要结局

  • Pain(At 3 and 6 months.)
  • Function(At 3 and 6 months.)

研究者

发起方
University Hospital, Linkoeping
申办方类型
Other
责任方
Principal Investigator
主要研究者

Torsten Johansson

MD, PhD

University Hospital, Linkoeping

研究点 (2)

Loading locations...

相似试验